I understand financials and have yet to be abused ... looking forward to it
Precisely which financials do you consider to be compelling right now?
The crucial issues are surely medical, ahead of future earnings?
Let's not put the cart (financials) before the horse (test results)
Assessinf future financials based on test and trial success is fair enough.
Uncertainty is what analysts and the common herd struggle to measure
What exactly are your concerns about FreeFromStyle's input ?
Regards, Recherche
Opthea Q and A, page-18
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
77.8¢ |
Change
-0.003(0.32%) |
Mkt cap ! $957.1M | |||
| Open | High | Low | Value | Volume |
| 79.5¢ | 81.3¢ | 77.3¢ | $1.786M | 2.241M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 33344 | 77.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 78.0¢ | 23621 | 25 |
View Market Depth
| Last trade - 13.44pm 30/09/2024 (20 minute delay) ? |
| OPT (ASX) Chart |